Filing Details
- Accession Number:
- 0000899243-20-006984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-04 17:42:56
- Reporting Period:
- 2020-03-02
- Accepted Time:
- 2020-03-04 17:42:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc. | MYOK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1413822 | Anastasios Gianakakos | C/O Myokardia, Inc. 1000 Sierra Point Parkway Brisbane CA 94005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-02 | 1,108 | $63.40 | 85,688 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-02 | 2,070 | $64.35 | 83,618 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-02 | 1,800 | $65.19 | 81,818 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-02 | 22 | $65.97 | 81,796 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 225,947 | Indirect | By Reporting Person's Trust 2 |
| Common Stock | 323,526 | Indirect | By Reporting Person's Trust 3 |
| Common Stock | 12,200 | Indirect | By Trust 1 |
| Common Stock | 12,200 | Indirect | By Trust 2 |
| Common Stock | 12,200 | Indirect | By Trust 3 |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents the weighted average sale price of the shares sold ranging from $62.77 to $63.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2 through 4.
- Represents the weighted average sale price of the shares sold ranging from $63.80 to $64.74 per share.
- Represents the weighted average sale price of the shares sold ranging from $64.89 to $65.82 per share.
Billionaire Hedge Funds
